Hyperhomocysteinemia is recognized as a risk factor for several diseases, including
cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite …

Increased plasma homocysteine (Hcy) is a significant and independent risk factor for
cardiovascular disease. It can cause multi-disease manifestations such as smooth muscle …

Neurodegenerative diseases are the diseases of the central nervous system with various
aetiology and symptoms. Dementia, Alzheimer's disease (AD), Parkinson's disease (PD) …

Homocysteine (Hcy) is a thiol group containing the amino acid, which naturally occurs in all
humans. Hcy is degraded in the body through two metabolic pathways, while a minor part is …

In the last 10 years, homocysteine has been regarded as a marker of cardiovascular disease
and a definite risk factor for many other diseases. Homocysteine is biosynthesized from …

Cysteine and homocysteine (Hcy), both sulfur‐containing amino acids (AAs), produced from
methionine another sulfur‐containing amino acid, which is converted to Hcy and further …

Increased plasma homocysteine is a risk factor for several pathological disorders. The
present review focused on the role of homocysteine (Hcy) in different population groups …

Homocysteine (Hcy) is a sulfhydryl-containing amino acid, and intermediate metabolite
formed in metabolising methionine (Met) to cysteine (Cys); defective Met metabolism can …

Hyperhomocysteinemia is the result of a disturbed methionine metabolism. It results from
enzyme and/or vitamin deficiency. Epidemiological studies have proven, that …

Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for various
significant medical conditions, yet controversy persists around its assessment and …